Proteomic analysis of melanoma‐derived exosomes by two‐dimensional polyacrylamide gel electrophoresis and mass spectrometry

Exosomes are 40–100 nm vesicles released by numerous cell types and are thought to have a variety of roles depending on their origin. Exosomes derived from antigen presenting cells have been shown to be capable of initiating immune responses in vivo and eradicating established tumours in murine models. Tumour‐derived exosomes can be utilised as a source of tumour antigen for cross‐priming to T‐cells and are thus of interest for use in anti‐tumour immunotherapy. Further exploration into the protein composition of exosomes may increase our understanding of their potential roles in vivo and this study has examined the proteome of exosomes purified from cell supernatants of the melanoma cell lines MeWo and SK‐MEL‐28. The vesicular nature and size (30–100 nm) of the purified exosomes was confirmed by electron microscopy and sucrose density gradient centrifugation. Western blotting demonstrated the absence of calnexin and cytochrome c, verifying the purity of the exosome preparations, as well as enrichment of MHC class I and the tumour‐associated antigens Mart‐1 and Mel‐CAM. The two‐dimensional polyarcylamide gel electrophoresis (2‐D PAGE) protein profiles of exosomes from the two cell lines were highly comparable and strikingly different from the profiles of the total cell lysates. Mass spectrometric sequencing identified proteins present in 49 protein spots in the exosome lysates. Several of these have been identified previously in exosomes but some are novel, including p120 catenin, radixin, and immunoglobulin superfamily member 8 (PGRL). Proteins present in whole‐cell lysates that were significantly reduced or excluded from exosomes were also identified and included several mitochondrial and lysosomal proteins, again confirming the proposed endosomal origin of exosomes. This study presents a starting point for future more in‐depth protein studies of tumour‐derived exosomes which will aid the understanding of their biogenesis and targeting for use in anti‐tumour immunotherapy protocols.

[1]  A. Trautmann,et al.  ERM proteins regulate cytoskeleton relaxation promoting T cell–APC conjugation , 2004, Nature Immunology.

[2]  L. Zitvogel,et al.  Exosome-based immunotherapy , 2004, Cancer Immunology, Immunotherapy.

[3]  M. Hemler Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. , 2003, Annual review of cell and developmental biology.

[4]  C. Usal,et al.  Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection1 , 2003, Transplantation.

[5]  F. Faure,et al.  Exosomes bearing HLA-G are released by melanoma cells. , 2003, Human immunology.

[6]  J. Thyberg,et al.  Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid , 2003, European Respiratory Journal.

[7]  David K Wilson,et al.  The Structure of Aip1p, a WD Repeat Protein That Regulates Cofilin-mediated Actin Depolymerization* , 2003, Journal of Biological Chemistry.

[8]  M. Knowles,et al.  Proteomic changes in renal cancer and co‐ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect , 2003, Proteomics.

[9]  P. Shannon,et al.  Proteomic analysis of human prostasomes , 2003, The Prostate.

[10]  Lei Liu,et al.  EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells. , 2003, Cancer research.

[11]  J. Sprent,et al.  Direct stimulation of naïve T cells by membrane vesicles from antigen-presenting cells: Distinct roles for CD54 and B7 molecules , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Hess,et al.  Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. , 2003, Experimental cell research.

[13]  P. Selby,et al.  Use of a sensitive EnVision™+‐based detection system for Western blotting: avoidance of streptavidin binding to endogenous biotin and biotin‐containing proteins in kidney and other tissues , 2003, Proteomics.

[14]  J. Slot,et al.  Proteomic and Biochemical Analyses of Human B Cell-derived Exosomes , 2003, The Journal of Biological Chemistry.

[15]  G. Birkenmeier,et al.  Mast Cell-Derived Exosomes Induce Phenotypic and Functional Maturation of Dendritic Cells and Elicit Specific Immune Responses In Vivo1 , 2003, The Journal of Immunology.

[16]  V. Santoni,et al.  Evaluation of nonionic and zwitterionic detergents as membrane protein solubilizers in two‐dimensional electrophoresis , 2003, Proteomics.

[17]  M. Stridsberg,et al.  Characteristics of human prostasomes isolated from three different sources , 2003, The Prostate.

[18]  Irving E. Vega,et al.  The septin protein Nedd5 associates with both the exocyst complex and microtubules and disruption of its GTPase activity promotes aberrant neurite sprouting in PC12 cells , 2003, Neuroreport.

[19]  L. Zitvogel,et al.  Tumor-derived exosomes: a new source of tumor rejection antigens. , 2002, Vaccine.

[20]  J. Le Pecq,et al.  Production and characterization of clinical grade exosomes derived from dendritic cells. , 2002, Journal of immunological methods.

[21]  Laurence Zitvogel,et al.  Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.

[22]  L. Zitvogel,et al.  Malignant effusions and immunogenic tumour-derived exosomes , 2002, The Lancet.

[23]  V. Chennathukuzhi,et al.  Identification and characterization of cDNAs encoding four novel proteins that interact with translin associated factor-X. , 2002, Genomics.

[24]  Lin Chen,et al.  Renal cell carcinoma related novel gene, GYLZ-RCC18: cloning and functional studies. , 2002, Chinese medical journal.

[25]  A. Régnault,et al.  TCR Activation of Human T Cells Induces the Production of Exosomes Bearing the TCR/CD3/ζ Complex1 , 2002, The Journal of Immunology.

[26]  M. Amin,et al.  Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression. , 2001, Gene.

[27]  T. V. Kolesnikova,et al.  EWI-2 Is a Major CD9 and CD81 Partner and Member of a Novel Ig Protein Subfamily* , 2001, The Journal of Biological Chemistry.

[28]  R. North,et al.  Rapid secretion of interleukin-1β by microvesicle shedding , 2001 .

[29]  M. Karlsson,et al.  "Tolerosomes" are produced by intestinal epithelial cells , 2001, European journal of immunology.

[30]  G. Raposo,et al.  Intestinal epithelial cells secrete exosome-like vesicles. , 2001, Gastroenterology.

[31]  P. Ricciardi-Castagnoli,et al.  Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles1 , 2001, The Journal of Immunology.

[32]  Kylie L. Gorringe,et al.  Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers : a new approach for the molecular analysis of paraffin-embedded cancer tissue. , 2001, The American journal of pathology.

[33]  H. Asada,et al.  Clonal nature of seborrheic keratosis demonstrated by using the polymorphism of the human androgen receptor locus as a marker. , 2001, The Journal of investigative dermatology.

[34]  R. Turner,et al.  Molecular clonality of in-transit melanoma metastasis. , 2001, The American journal of pathology.

[35]  A. Namane,et al.  Nonspecific B and T Cell-Stimulatory Activity Mediated by Mast CellsIs Associated with Exosomes , 2001, International Archives of Allergy and Immunology.

[36]  Laurence Zitvogel,et al.  Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming , 2001, Nature Medicine.

[37]  A. Namane,et al.  Mast Cell-Dependent B and T Lymphocyte Activation Is Mediated by the Secretion of Immunologically Active Exosomes1 , 2001, The Journal of Immunology.

[38]  R. Wait,et al.  A modified silver staining protocol for visualization of proteins compatible with matrix‐assisted laser desorption/ionization and electrospray ionization‐ mass spectrometry , 2000, Electrophoresis.

[39]  M. Kleijmeer,et al.  Follicular Dendritic Cells Carry MHC Class II-Expressing Microvesicles at Their Surface1 , 2000, The Journal of Immunology.

[40]  S. Pentyala,et al.  Prostasomes: Current concepts , 2000, The Prostate.

[41]  J. Sixma,et al.  Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules , 1999 .

[42]  Laurence Zitvogel,et al.  Molecular Characterization of Dendritic Cell-Derived Exosomes , 1999, The Journal of cell biology.

[43]  H. Geuze,et al.  Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes* , 1998, The Journal of Biological Chemistry.

[44]  T. Rabilloud Use of thiourea to increase the solubility of membrane proteins in two‐dimensional electrophoresis , 1998, Electrophoresis.

[45]  Ichikawa,et al.  Moesin and CD44 expression in cutaneous melanocytic tumours , 1998, The British journal of dermatology.

[46]  Laurence Zitvogel,et al.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes , 1998, Nature Medicine.

[47]  C. Hess,et al.  Ectosomes released by human neutrophils are specialized functional units. , 1998, Journal of immunology.

[48]  Y. Hiraoka,et al.  Nedd5, a mammalian septin, is a novel cytoskeletal component interacting with actin-based structures. , 1997, Genes & development.

[49]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[50]  R. Johnstone,et al.  Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions. , 1989, Blood.

[51]  Peter J. Peters,et al.  Molecules relevant for T cell‐target cell interaction are present in cytolytic granules of human T lymphocytes , 1989, European journal of immunology.

[52]  R. Johnstone,et al.  Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). , 1987, The Journal of biological chemistry.

[53]  J. Lehmann,et al.  Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. , 1987, Cancer research.

[54]  E. Trams,et al.  Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. , 1981, Biochimica et biophysica acta.

[55]  M. Mason,et al.  Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. , 2001, Journal of immunological methods.

[56]  T. Südhof,et al.  Membrane fusion and exocytosis. , 1999, Annual review of biochemistry.

[57]  G. Ronquist,et al.  Phospholipase A2 activity in prostasomes from human seminal plasma. , 1987, Urologia internationalis.